Point72 Asia (Singapore) Pte. Ltd. Macrogenics Inc Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $646 Billion
- Q3 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Macrogenics Inc stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 25,105 shares of MGNX stock, worth $38,661. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,105
Previous 50,211
50.0%
Holding current value
$38,661
Previous $60.8 Million
30.58%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding MGNX
# of Institutions
107Shares Held
50MCall Options Held
65.5KPut Options Held
93.9K-
Bellevue Group Ag Kuesnacht, V89.92MShares$15.3 Million0.36% of portfolio
-
Armistice Capital, LLC New York, NY5.96MShares$9.18 Million0.16% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$8.32 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$6.51 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.18MShares$4.89 Million0.23% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $94.6M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...